Los Angeles, CA, United States of America

Hualin Fu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Southern California. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hualin Fu. Retrieved from https://idiyas.com/inventor/hualin-fu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hualin Fu and Cancer-Related DNA Methylation Markers.

Introduction

Hualin Fu is an inventor associated with the University of Southern California in Los Angeles, California. His patent work concerns DNA methylation patterns that may help identify and characterize human cancers.

Latest Patents

Fu is associated with 1 patent, titled “Methylation Altered DNA Sequences as Markers Associated with Human Cancer.” The patent describes 103 methylation-altered DNA sequences with patterns that differ between cancerous and normal tissue. Some sequences were reported as novel, and the patent describes potential uses in cancer diagnosis, prognosis, and treatment, as well as in kits for detecting methylated CpG-containing nucleic acids. The disclosure discusses cancers including bladder and prostate cancer.

Career Highlights

Fu’s listed patent reflects research into molecular markers and their potential applications in cancer care. The work focuses on distinguishing cancer-associated methylation patterns from those found in normal tissue.

Collaborations

Fu’s listed coworkers include Isabel D. C. Markl and Yoshitaka Tomigahara. The patent’s association with the University of Southern California connects this work to the university’s research community.

Conclusion

Hualin Fu’s patent describes a set of DNA methylation markers with potential diagnostic, prognostic, and therapeutic applications in human cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…